ArticleMedComm2026
Gas Biopsy of Pleural Effusion to Diagnose Lung Cancer by Mass Spectrometry.
Wenting Liu, Jian Qi, Yajing Chu, Jijuan Zhou, Yue Liu, Li Ke, Xiangxue Zheng, Yan Lu, Dianlong Ge, Yannan Chu and 1 more
Abstract read
In one paragraphArticle in MedComm, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Wenting LiuHefei Cancer Hospital of CAS Institute of Health and Medical Technology, Hefei Institutes of Physical Science Chinese Academy of Sciences (CAS) Hefei Anhui China.ORCID https://orcid.org/0009-0007-7592-4813 Yajing ChuKey Laboratory of Biodiversity Conservation and Characteristic Resource Utilization in Southwest Anhui School of Life Sciences Anqing Forestry Technology Innovation Research Institute Anqing Normal University Anhui China.
Jijuan ZhouHefei Cancer Hospital of CAS Institute of Health and Medical Technology, Hefei Institutes of Physical Science Chinese Academy of Sciences (CAS) Hefei Anhui China.
Yue LiuHefei Cancer Hospital of CAS Institute of Health and Medical Technology, Hefei Institutes of Physical Science Chinese Academy of Sciences (CAS) Hefei Anhui China.
Li KeHefei Cancer Hospital of CAS Institute of Health and Medical Technology, Hefei Institutes of Physical Science Chinese Academy of Sciences (CAS) Hefei Anhui China.
Xiangxue ZhengHefei Cancer Hospital of CAS Institute of Health and Medical Technology, Hefei Institutes of Physical Science Chinese Academy of Sciences (CAS) Hefei Anhui China.
Yan LuHefei Cancer Hospital of CAS Institute of Health and Medical Technology, Hefei Institutes of Physical Science Chinese Academy of Sciences (CAS) Hefei Anhui China.
Dianlong GeHefei Cancer Hospital of CAS Institute of Health and Medical Technology, Hefei Institutes of Physical Science Chinese Academy of Sciences (CAS) Hefei Anhui China.
Yannan ChuHefei Cancer Hospital of CAS Institute of Health and Medical Technology, Hefei Institutes of Physical Science Chinese Academy of Sciences (CAS) Hefei Anhui China.
Hongzhi WangHefei Cancer Hospital of CAS Institute of Health and Medical Technology, Hefei Institutes of Physical Science Chinese Academy of Sciences (CAS) Hefei Anhui China.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Lung cancer (LC) is a leading cause of cancer mortality worldwide, frequently complicated by malignant pleural effusion (MPE). This study aimed to investigate volatile organic compounds (VOCs) in pleural effusion to identify metabolic biomarkers for LC. A total of 107 LC-related MPE and 112 benign pleural effusion (BPE) patients were enrolled and divided into discovery (MPE:
Indexed as
gas biopsylung cancerpleural effusiontumor tissuevolatile organic compounds
Identifiers
PMID42253921
PMCPMC13238847
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390